Lack of Correlation between Plasmatic Levels of Retinol and RBP and Thyroid Hormones in Breast Cancer Patients Treated with the Synthetic Retinoid Fenretinide
Restricted accessLetterFirst published online October, 1990
Lack of Correlation between Plasmatic Levels of Retinol and RBP and Thyroid Hormones in Breast Cancer Patients Treated with the Synthetic Retinoid Fenretinide
MoonR.C., ThompsonH.J., BecciJ.P.N (4 Hydroxyph-enil) retinamide. A new retinoid for prevention of breast cancer in the rat. Cancer Res1979; 39: 1339–46.
2.
WelschC.W., DeHoogJ.V., MoonR.C.Inhibition of mammary tumorgenesis in nulliparous C3H mice by chronic feeding of the synthetic retinoid, N (4 hydrpxyphenil) retinamide. Carcinogenesis1983; 4: 1185–7.
3.
FormelliF., CarsanaR., CostaA.N (4hydroxyphenyl) retinamide (4HPR) lowers plasma retinol levels in rats. Med Sci Res1987; 15: 843–4.
4.
FormelliF., CarsanaR., CostaA.Plasma retinol level reduction by the synthetic retinoid Fenretinide: a one year follow up study of breast cancer patients. Cancer Res1989; 49: 6149–52.
5.
LippmanS.M., KesslerJ.F., MeyskensF.L.Retinoids as preventive annd therapeutic anticancer agents (Part I). Cancer Treat Rep1987; 4: 391–405.
